Several of the highest-profile AI-biology startups have made openness part of their strategy. Profluent, an Emeryville-based protein design company, open-sourced OpenCRISPR-1, which it calls the first AI-created gene editor to successfully modify human DNA, and says tens of thousands of researchers have accessed it since 2024. Xaira Therapeutics, co-founded by Nobel laureate David Baker with… The post Cradle co-founder Elise de Reus on why openn…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.